Lowering the risk of visual impairment and blindness

Diabetic Medicine

Volumn 15, Issue SUPPL. 4, 1998, Pages

  Cunha Vaz, José ^a  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

Author keywords

Blindness; Diabetes mellitus; Diabetic retinopathy; Photocoagulation; Visual impairment

Indexed keywords

BLINDNESS; BLOOD GLUCOSE MONITORING; COST BENEFIT ANALYSIS; DIABETES CONTROL; DIABETIC RETINOPATHY; DISEASE COURSE; EARLY DIAGNOSIS; HEALTH CARE COST; HUMAN; LASER COAGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PRACTICE GUIDELINE; PREVALENCE; REVIEW; RISK ASSESSMENT;

ADULT; BLINDNESS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; GREAT BRITAIN; HUMANS; INCIDENCE; MULTICENTER STUDIES; PRACTICE GUIDELINES; PREVALENCE; RISK FACTORS; VISION DISORDERS;

EID: 0031768551     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1096-9136(1998120)15:4+3.3.co;2-j     Document Type: Article

References (18)

1. Klein R, Klein BEK, Moss SE. The epidemiology of ocular problems in diabetes mellitus. In: SS Feman, Ocular Problems in Diabetes Mellitus. Boston: Blackwell Scientific Publications, 1992: 1-5.
2. King H. The epidemic of NIDDM: an epidemiological perspective. Int. Diab Fed Bull 1995; 40: 10-12.
3. Jerneld B. Prevalence of diabetic retinopathy. A population study from the Swedish Island of Gotland. Acta Ophthalmol 1988; 188 (Suppl): 3-32.
4. Nielsen NV. Diabetic retinopathy I. The course of retinopathy in insulin-treated diabetics. A one-year epidemiological cohort study of diabetes mellitus. The Island of Falster, Denmark. Acta Ophthalmol (Copenh) 1984; 62 (2): 256-265.
5. Nielsen NV. Diabetic retinopathy II. The course of retinopathy in diabetics treated with oral hypoglycaemic agents and diet regime alone. A one year epidemiological cohort study of diabetes mellitus. The Island of Falster, Denmark. Acta Ophthalmol (Copenh) 1984; 62 (2): 266-273.
6. Klein R, Klein BE, Moss SE, et al. The Wiscosin Epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1984; 102 (4): 520-526.
7. Klein R, Klein BE, Moss SE et al. The Wiscosin Epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 1984; 102 (4): 527-532.
8. Diabetes Control and Complications Trial. The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin dependent diabetes mellitus. Arch Ophthalmol 1995; 113 (1): 36-51.
9. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with Type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853.
10. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol 1985; 103 (12): 1796-1806.
11. Diabetic Retinopathy Study Research Group. Photocoagulation treatment of proliferative diabetic retinopathy. Clinical applications of Diabetic Retinopathy Study (DRS) findings. DRS Report Number 8. Ophthalmology 1981; 88 (7): 583-600.
12. Ohkubo Y, Kishikawa H, Araki E et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 1995; 28 (2): 103-117.
13. UK Prospective Diabetes Study Group. Tight blood-pressure control and risk of macrovascular and microvascular complications in Type 2 diabetes: UKPDS 38. BMJ 1998; 317: 703-712.
14. Fendrick AM, Javitt JC, Chaing YP. Cost-effectiveness of the screening and treatment of diabetic retinopathy. What are the costs of underutilization? Int J Technol Assess Health Care 1992; 8 (4): 694-707.
15. UK Prospective Diabetes Study (UKPDS) Group. Cost effectiveness analysis of improved blood-pressure control in hypertensive Type 2 diabetes patients: UKPDS 40. BMJ 1998; 317: 720-726.
16. Backlund LB, Algvere PV, Rosenqvist U. New blindness in diabetes reduced by more than one-third in Stockholm County. Diabet Med 1997; 14 (9): 732-740.
17. Cunha-Vaz JG. Perspectives in the treatment of diabetic retinopathy [review]. Diabetes Metab Rev 1992; 8 (2): 105-116.
18. Cunha-Vaz JG and Lobo C. Medical therapy of diabetic retinopathy. Exp Ophthalmol 1998; 24 (1): 1-5.